Quentin Liu Selected Research

Small Interfering RNA (siRNA)

4/2016	hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.
4/2015	Ku80 cooperates with CBP to promote COX-2 expression and tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quentin Liu Research Topics

Disease

102	Neoplasms (Cancer) 04/2024 - 05/2008
28	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2010
17	Nasopharyngeal Carcinoma 06/2023 - 05/2008
14	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2010
14	Carcinogenesis 01/2022 - 10/2008
13	Lung Neoplasms (Lung Cancer) 09/2023 - 07/2014
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 03/2008
10	Leukemia 11/2023 - 03/2008
6	Stomach Neoplasms (Stomach Cancer) 12/2018 - 02/2009
5	Carcinoma (Carcinomatosis) 01/2023 - 05/2008
5	Adenocarcinoma 07/2020 - 01/2013
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2016 - 03/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2013
4	Disease Progression 02/2023 - 03/2013
4	Triple Negative Breast Neoplasms 11/2022 - 01/2016
4	Polyploidy 11/2016 - 11/2013
3	Lymphatic Metastasis 02/2024 - 07/2014
3	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 08/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2023 - 01/2015
2	Stroke (Strokes) 01/2023 - 07/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 08/2016
2	Hypoxia (Hypoxemia) 11/2022 - 03/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 07/2020 - 07/2008
2	Anaplastic Thyroid Carcinoma 08/2018 - 07/2018
2	Infections 07/2018 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 11/2016
2	Epilepsy (Aura) 11/2016 - 08/2014
2	Acute Promyelocytic Leukemia 01/2014 - 05/2011
2	Aneuploidy (Aneuploid) 07/2008 - 05/2008
1	Muscular Atrophy (Muscle Atrophy) 04/2024
1	Cachexia 04/2024
1	Melanoma (Melanoma, Malignant) 04/2024

Drug/Important Bio-Agent (IBA)

20	Aurora Kinase AIBA 03/2024 - 08/2009
16	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2011
14	Phosphotransferases (Kinase)IBA 02/2023 - 11/2007
11	Aurora KinasesIBA 05/2022 - 03/2008
10	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2011
8	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2018
7	Beclin-1IBA 01/2023 - 04/2010
6	tozasertibIBA 11/2013 - 03/2008
5	CateninsIBA 04/2024 - 11/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 07/2014
4	Cadherins (E-Cadherin)IBA 04/2024 - 10/2008
4	Histones (Histone)IBA 01/2023 - 05/2008
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2013
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2016
4	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 10/2014
4	Sirolimus (Rapamycin)FDA Link 05/2016 - 11/2013
3	6-methyladenineIBA 04/2024 - 01/2021
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2024 - 11/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 07/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2016
3	Caspase 3 (Caspase-3)IBA 07/2018 - 05/2008
3	AKI603IBA 11/2016 - 08/2014
3	Carrier Proteins (Binding Protein)IBA 10/2016 - 09/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016 - 04/2015
3	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 08/2015 - 05/2008
2	Amino Acids FDA Link 03/2024 - 10/2023
2	Small Cytoplasmic RNAIBA 11/2023 - 02/2023
2	mangostinIBA 11/2023 - 03/2014
2	Amphibian VenomsIBA 09/2023 - 08/2014
2	gamabufotalinIBA 09/2023 - 08/2014
2	bufadienolideIBA 09/2023 - 08/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 04/2021
2	UbiquitinIBA 01/2023 - 01/2022
2	IronIBA 01/2023 - 11/2021
2	EnzymesIBA 01/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2023 - 05/2008
2	Long Noncoding RNAIBA 11/2022 - 01/2019
2	LigandsIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2020
2	PlatinumIBA 01/2022 - 07/2014
2	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2018
2	MLN 8237IBA 01/2021 - 01/2021
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2014
2	RetinoidsIBA 01/2020 - 05/2011
2	RNA Splicing FactorsIBA 12/2018 - 09/2014
2	VimentinIBA 10/2017 - 03/2015
2	CaspasesIBA 11/2016 - 05/2016
2	Small Interfering RNA (siRNA)IBA 04/2016 - 04/2015
2	Autophagy-Related ProteinsIBA 01/2016 - 03/2012
2	ChromatinIBA 01/2016 - 10/2014
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2010 - 11/2009
1	Interleukin-1 Type II ReceptorsIBA 04/2024
1	AsparagineIBA 03/2024
1	taxaneIBA 03/2024

Therapy/Procedure

49	Therapeutics 04/2024 - 08/2008
13	Drug Therapy (Chemotherapy) 11/2023 - 11/2009
8	Immunotherapy 04/2024 - 01/2020
6	Radiotherapy 11/2023 - 08/2018
4	Chemoradiotherapy 01/2022 - 11/2019
2	Induction Chemotherapy 01/2022 - 05/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 11/2015
2	Transplantation 08/2016 - 11/2011
1	Low-Level Light Therapy (LLLT) 04/2024